Skip to main content
Annals of Intensive Care
Fig. 3 | Annals of Intensive Care

Fig. 3

From: Response to different furosemide doses predicts AKI progression in ICU patients with elevated plasma NGAL levels

Fig. 3

Prediction of AKI progression by biomarkers and furosemide responsiveness (FR). Receiver operating characteristic curves (ROC) in a progression to AKI stage 3 and b progression to AKI stage 3 or death at 1 week. NGAL, neutrophil gelatinase-associated lipocalin; L-FABP, L-type fatty acid binding protein; NAG, N-acetyl-β-d-glucosaminidase; FR, furosemide responsiveness

Back to article page